Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs
Open Access
- 29 July 2025
- journal article
- review article
- Published by Springer Nature in Communications Chemistry
- Vol. 8 (1) , 218
Abstract
PROteolysis-Targeting Chimeras (PROTACs) are an emerging class of molecules capable of inducing a forced approximation between a protein of interest (POI) and an E3 ligase enzyme (e.g., Cereblon), leading to the degradation of the POI by the cell’s own machinery. Although in early stages of development, PROTACs’ unique mechanisms of action offer a novel therapeutic strategy, which has attracted growing interest worldwide. Cereblon-based PROTACs are the most studied class of PROTACs and have been actively researched in recent years for the treatment of different diseases, from cancer to neurological disorders, with some of them already in clinical trials. In this review, we provide a comprehensive and critical analysis covering the recent advances, potential challenges and future prospects regarding the design and synthesis, as well as pre- and clinical evaluation of cereblon-based PROTACs. By integrating insights from drug discovery and development, a broad yet in-depth discussion is given to guide future research on cereblon-based PROTACs.Keywords
Funding Information
- Ministry of Education and Science | Fundação para a Ciência e a Tecnologia (2023.03179.BD, SFRH/BD/138674/2018)
This publication has 231 references indexed in Scilit:
- Identification of a Primary Target of Thalidomide TeratogenicityScience, 2010
- New thalidomide analogues derived through Sonogashira or Suzuki reactions and their TNF expression inhibition profilesBioorganic & Medicinal Chemistry, 2010
- Cu-Catalyzed Azide−Alkyne CycloadditionChemical Reviews, 2008
- Drug discovery in the ubiquitin–proteasome systemNature Reviews Drug Discovery, 2006
- A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardationNeurology, 2004
- Facile Synthesis of an Azido-Labeled Thalidomide AnalogueOrganic Letters, 2003
- Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradationProceedings of the National Academy of Sciences, 2001
- Click Chemistry: Diverse Chemical Function from a Few Good ReactionsAngewandte Chemie International Edition, 2001
- THE METABOLISM OF THALIDOMIDE: THE FATE OF THALIDOMIDE AND SOME OF ITS HYDROLYSIS PRODUCTS IN VARIOUS SPECIESBritish Journal of Pharmacology and Chemotherapy, 1965
- THE METABOLISM OF THALIDOMIDE: THE SPONTANEOUS HYDROLYSIS OF THALIDOMIDE IN SOLUTIONBritish Journal of Pharmacology and Chemotherapy, 1965